RESUMEN
Aim The objective of this study was to evaluate the reliability and quality of YouTube™ (Google, Inc., Mountain View, CA) videos pertaining to anaesthesia awareness. Methods We evaluated the most commonly viewed 100 videos pertaining to anaesthesia awareness. The YouTube™ videos' image type, qualification of the uploaders, video content, video length in minutes, upload time, time since upload, total view count, daily view count and comment and like counts were recorded. The quality of the YouTube™ videos was evaluated using the Global Quality Scale (GQS), and the reliability was determined using the modified DISCERN scale. Results Of all videos, 34 (34%) were uploaded directly by physicians, 16 (16%) by patients, 14 (14%) by health channels, 13 (13%) by TV shows and 23 (23%) by others. The mean video length was 11.48±11.96 minutes. The average DISCERN score was 4.47±0.58 in the professional and 3.28±0.65 in the non-professional video group (p<0.001). The mean GQS score was 4.47±0.52 in the professional and 3.35±0.67 in the non-professional video group (p<0.001). Conclusion The results of this study indicate that a significant portion of the YouTube™ videos pertaining to anaesthesia awareness were uploaded directly by physicians or by health channels. Physicians and professional health institutions should be promoted to provide accurate and more reliable videos to direct patients to the right solutions for their problems. YouTube™ videos should be subjected to supervision before they can be publicly viewed.
RESUMEN
Background In this retrospective study, we aimed to investigate the effect of chlorhexidine digluconate-flurbiprofen spray (Klorhex Plus® oral spray) on postoperative sore throat (POST) and hoarseness (POH) in patients undergoing rhinoplasty. Methodology Patients who underwent rhinoplasty alone in our clinic between April 01, 2021, and February 28, 2022, were enrolled in the study. Patients' demographics such as age, gender, height, and smoking status that could affect sore throat, difficult intubation, and operation time were recorded from the patients' files. Patients were grouped as those who received Klorhex Plus oral spray before the surgery (Klorhex P group) and those who did not (control group). POST and POH were recorded from the patients' postoperative surgery files. Postoperative pain evaluation was performed using the Numerical Rating Scale (NRS) at the postoperative first hour (PPL1h), 12th hour (PPL12h), and first day (PPL1d) from the postoperative nursing files. Results A total of 354 patients who underwent rhinoplasty alone were included in this study. No significant difference was found between the groups in terms of the demographic data. Statistically, PPL1h, PPL12h, and PPL1d were significantly lower in the Klorhex P group compared to the control group (for all, p < 0.001). POST and POH were also significantly higher in the control group (both, p < 0.001). Conclusions The results of this study indicate that Klorhex Plus oral spray is an efficient agent for preemptive analgesia before rhinoplasty. It significantly decreases the postoperative pain level, POST, and POH. However, further comprehensive prospective studies are needed to introduce Klorhex Plus oral spray to rhinology practice.